These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25874154)

  • 41. Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Raška I; Rašková M; Zikán V; Škrha J
    Cent Eur J Public Health; 2017 Mar; 25(1):3-10. PubMed ID: 28399348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis.
    Aung M; Amin S; Gulraiz A; Gandhi FR; Pena Escobar JA; Malik BH
    Cureus; 2020 Sep; 12(9):e10412. PubMed ID: 33062529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diabetes Mellitus and bone metabolism].
    Okazaki R
    Clin Calcium; 2011 May; 21(5):669-75. PubMed ID: 21532115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of type 2 diabetes on bone metabolism.
    Sanches CP; Vianna AGD; Barreto FC
    Diabetol Metab Syndr; 2017; 9():85. PubMed ID: 29075333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Lifestyle-related disease associated osteoporosis: Diabetes].
    Yamamoto M
    Clin Calcium; 2015 Sep; 25(9):1319-27. PubMed ID: 26320532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
    Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
    BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients.
    Goldshtein I; Nguyen AM; dePapp AE; Ish-Shalom S; Chandler JM; Chodick G; Shalev V
    Arch Osteoporos; 2018 Mar; 13(1):15. PubMed ID: 29502187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of impaired bone strength in type 1 and 2 diabetes.
    Merlotti D; Gennari L; Dotta F; Lauro D; Nuti R
    Nutr Metab Cardiovasc Dis; 2010 Nov; 20(9):683-90. PubMed ID: 20934862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment for osteoporosis in people with ß-thalassaemia.
    Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
    Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of bone quality in patients with diabetes mellitus.
    Jiang N; Xia W
    Osteoporos Int; 2018 Aug; 29(8):1721-1736. PubMed ID: 29736760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the relationship between type 2 diabetes and osteoporosis using Bayesian inference.
    Sta Romana M; Li-Yu JT
    J Clin Densitom; 2007; 10(4):386-90. PubMed ID: 17993401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of Osteoporosis Therapies in Diabetic Patients.
    Schwartz AV
    Calcif Tissue Int; 2017 Feb; 100(2):165-173. PubMed ID: 27461216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone metabolism and fracture risk in type 2 diabetes mellitus [Review].
    Yamaguchi T; Sugimoto T
    Endocr J; 2011; 58(8):613-24. PubMed ID: 21778617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical epidemiology of male osteoporosis: a review of the recent literature.
    Willson T; Nelson SD; Newbold J; Nelson RE; LaFleur J
    Clin Epidemiol; 2015; 7():65-76. PubMed ID: 25657593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone mineral density in patients with longstanding type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
    Alhuzaim ON; Lewis EJH; Lovblom LE; Cardinez M; Scarr D; Boulet G; Weisman A; Lovshin JA; Lytvyn Y; Keenan HA; Brent MH; Paul N; Bril V; Cherney DZI; Perkins BA
    J Diabetes Complications; 2019 Nov; 33(11):107324. PubMed ID: 31003922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.
    Anagnostis P; Paschou SA; Gkekas NN; Artzouchaltzi AM; Christou K; Stogiannou D; Vryonidou A; Potoupnis M; Goulis DG
    Endocrine; 2018 Jun; 60(3):373-383. PubMed ID: 29411304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diabetes and osteoporosis].
    Valkusz Z
    Orv Hetil; 2011 Jul; 152(29):1161-6. PubMed ID: 21712181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diabetes-related osteoporosis].
    Kanazawa I
    Nihon Rinsho; 2015 Oct; 73(10):1718-22. PubMed ID: 26529936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone health in diabetes: considerations for clinical management.
    Adami S
    Curr Med Res Opin; 2009 May; 25(5):1057-72. PubMed ID: 19292601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Type 2 diabetes mellitus and bone.
    Compston J
    J Intern Med; 2018 Feb; 283(2):140-153. PubMed ID: 29265670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.